{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T06:38:39Z","timestamp":1778913519525,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,6,16]],"date-time":"2015-06-16T00:00:00Z","timestamp":1434412800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12872-015-0043-z","type":"journal-article","created":{"date-parts":[[2015,6,15]],"date-time":"2015-06-15T06:11:57Z","timestamp":1434348717000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Differentiation of infiltrative cardiomyopathy from hypertrophic cardiomyopathy using high-sensitivity cardiac troponin T: a case-control study"],"prefix":"10.1186","volume":"15","author":[{"given":"Toru","family":"Kubo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Baba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayoshi","family":"Hirota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsutoshi","family":"Tanioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohito","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeo","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuo","family":"Iiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"Kumagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Furuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuro","family":"Sugiura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Kitaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,6,16]]},"reference":[{"key":"43_CR1","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1056\/NEJM199709253371306","volume":"337","author":"RH Falk","year":"1997","unstructured":"Falk RH, Comenzo RL, Skinner M. The systemic amyloidosis. N Engl J Med. 1997;337:898\u2013909.","journal-title":"N Engl J Med"},{"key":"43_CR2","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/S0735-1097(85)80475-7","volume":"6","author":"L Cueto-Garcia","year":"1985","unstructured":"Cueto-Garcia L, Reeder GS, Kyle RA, Wood DL, Seward JB, Naessens J, et al. Echocardiographic findings in systemic amyloidosis: spectrum of cardiac involvement and relation to survival. J Am Coll Cardiol. 1985;6:737\u201343.","journal-title":"J Am Coll Cardiol"},{"key":"43_CR3","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/0002-9149(87)90948-9","volume":"59","author":"RH Falk","year":"1987","unstructured":"Falk RH, Plehn JF, Deering T, Schick Jr EC, Boinay P, Rubinow A, et al. Sensitivity and specificity of the echocardiographic features of cardiac amyloidosis. Am J Cardiol. 1987;59:418\u201322.","journal-title":"Am J Cardiol"},{"key":"43_CR4","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1067\/mje.2002.125285","volume":"15","author":"P Palka","year":"2002","unstructured":"Palka P, Lange A, Donnelly JE, Scalia G, Burstow DJ, Nihoyannopoulos P. Doppler tissue echocardiographic features of cardiac amyloidosis. J Am Soc Echocardiogr. 2002;15:1353\u201360.","journal-title":"J Am Soc Echocardiogr"},{"key":"43_CR5","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.amjcard.2003.12.025","volume":"93","author":"T Oki","year":"2004","unstructured":"Oki T, Tanaka H, Yamada H, Tabata T, Oishi Y, Ishimoto T, et al. Diagnosis of cardiac amyloidosis based on the myocardial velocity profile in the hypertrophied left ventricular wall. Am J Cardiol. 2004;93:864\u20139.","journal-title":"Am J Cardiol"},{"key":"43_CR6","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1056\/NEJM199508033330504","volume":"333","author":"S Nakao","year":"1995","unstructured":"Nakao S, Takenaka T, Maeda M, Kodama C, Tanaka A, Tahara M, et al. An atypical variant of Fabry\u2019s disease in men with left ventricular hypertrophy. N Engl J Med. 1995;333:288\u201393.","journal-title":"N Engl J Med"},{"key":"43_CR7","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1161\/01.CIR.0000012626.81324.38","volume":"105","author":"B Sachdev","year":"2002","unstructured":"Sachdev B, Takenaka T, Teraguchi H, Tei C, Lee P, McKenna WJ, et al. Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy. Circulation. 2002;105:1407\u201311.","journal-title":"Circulation"},{"key":"43_CR8","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1016\/j.jacc.2007.06.062","volume":"50","author":"L Monserrat","year":"2007","unstructured":"Monserrat L, Gimeno-Blanes JR, Marin F, Hermida-Prieto M, Garcia-Honrubia A, Perez I, et al. Prevalence of Fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2007;50:2399\u2013403.","journal-title":"J Am Coll Cardiol"},{"key":"43_CR9","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1136\/heartjnl-2011-300364","volume":"97","author":"P Elliott","year":"2011","unstructured":"Elliott P, Baker R, Pasquale F, Quarta G, Ebrahim H, Mehta AB. Hughes DA, and ACES study group: Prevalence of Anderson-Fabry disease in patients with hypertrophic cardiomyopathy: the European Anderson-Fabry Disease Survey. Heart. 2011;97:1957\u201360.","journal-title":"Heart"},{"key":"43_CR10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s00392-007-0566-0","volume":"97","author":"F Weidmann","year":"2008","unstructured":"Weidmann F, Strotmann JM. Use of tissue Doppler imaging to identify and manage systemic diseases. Clin Res Cardiol. 2008;97:65\u201373.","journal-title":"Clin Res Cardiol"},{"key":"43_CR11","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1056\/NEJM199703133361107","volume":"336","author":"P Spirito","year":"1997","unstructured":"Spirito P, Seidman CE, McKenna WJ, Maron BJ. The management of hypertrophic cardiomyopathy. N Engl J Med. 1997;336:775\u201385.","journal-title":"N Engl J Med"},{"key":"43_CR12","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/S0735-1097(03)00941-0","volume":"42","author":"BJ Maron","year":"2003","unstructured":"Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, et al. American College of Cardiology\/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol. 2003;42:1687\u2013713.","journal-title":"J Am Coll Cardiol"},{"key":"43_CR13","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/S0140-6736(12)60397-3","volume":"381","author":"BJ Maron","year":"2013","unstructured":"Maron BJ, Maron MS. Hypertrophic cardiomyopathy. Lancet. 2013;381:242\u201355.","journal-title":"Lancet"},{"key":"43_CR14","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jjcc.2007.12.001","volume":"51","author":"T Takenaka","year":"2008","unstructured":"Takenaka T, Teraguchi H, Yoshida A, Taguchi S, Ninomiya K, Umekita Y, et al. Terminal stage cardiac findings in patients with cardiac Fabry disease: an electrocardiographic, echocardiographic, and autopsy study. J Cardiol. 2008;51:50\u20139.","journal-title":"J Cardiol"},{"key":"43_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJM200107053450102","volume":"345","author":"CM Eng","year":"2001","unstructured":"Eng CM, Guffon N, Wilcox WR, Germain DP, Lee P, Waldek S, et al. Safety and efficacy of recombinant human alpha-galactosidase A: replacement therapy in Fabry\u2019s disease. N Engl J Med. 2001;345:9\u201316.","journal-title":"N Engl J Med"},{"key":"43_CR16","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1161\/CIRCULATIONAHA.108.794529","volume":"119","author":"F Weidemann","year":"2009","unstructured":"Weidemann F, Niemann M, Breunig F, Herrmann S, Beer M, Stork S, et al. Long-term effects of enzyme replacement therapy on Fabry cardiomyopathy: evidence for a better outcome with early treatment. Circulation. 2009;119:524\u20139.","journal-title":"Circulation"},{"key":"43_CR17","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1136\/heartjnl-2013-305157","volume":"100","author":"Y Ochi","year":"2014","unstructured":"Ochi Y, Kubo T, Kitaoka H. Repeated heart failure in a 74-year-old man with left ventricular hypertrophy. Heart. 2014;100:710.","journal-title":"Heart"},{"key":"43_CR18","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1056\/NEJMoa0900428","volume":"361","author":"T Reichlin","year":"2009","unstructured":"Reichlin T, Hochholzer W, Bassetti S, Steuer S, Stelzig C, Hartwiger S, et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med. 2009;361:858\u201367.","journal-title":"N Engl J Med"},{"key":"43_CR19","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1056\/NEJMoa0903515","volume":"361","author":"T Keller","year":"2009","unstructured":"Keller T, Zeller T, Peetz D, Tzikas S, Roth A, Czyz E, et al. Sensitive troponin assay in early diagnosis of acute myocardial infarction. N Engl J Med. 2009;361:868\u201377.","journal-title":"N Engl J Med"},{"key":"43_CR20","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jjcc.2012.06.007","volume":"60","author":"Y Sato","year":"2012","unstructured":"Sato Y, Fujiwara H, Takatsu Y. Cardiac troponin and heart failure in the era of high-sensitivity assays. J Cardiol. 2012;60:160\u20137.","journal-title":"J Cardiol"},{"key":"43_CR21","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1161\/CIRCULATIONAHA.106.655076","volume":"116","author":"R Latini","year":"2007","unstructured":"Latini R, Masson S, Anand IS, Missov E, Carlson M, Vago T, et al. Nal-HeFT Investigators: Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure. Circulation. 2007;116:1242\u20139.","journal-title":"Circulation"},{"key":"43_CR22","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1182\/blood-2010-02-267708","volume":"116","author":"AV Kristen","year":"2010","unstructured":"Kristen AV, Giannitsis E, Lehrke S, Hegenbart U, Konstandin M, Lindenmaier D, et al. Assessment of disease severity and outcome in patients with systemic light-chain amyloidosis by the high-sensitivity troponin T assay. Blood. 2010;116:2455\u201361.","journal-title":"Blood"},{"key":"43_CR23","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1016\/j.amjcard.2012.05.061","volume":"110","author":"T Apridonidze","year":"2012","unstructured":"Apridonidze T, Steingart RM, Comenzo RL, Hoffman J, Goldsmith Y, Bella JN, et al. Clinical and echocardiographic correlates of elevated troponin in amyloid light-chain cardiac amyloidosis. Am J Cardiol. 2012;110:1180\u20134.","journal-title":"Am J Cardiol"},{"key":"43_CR24","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1136\/heartjnl-2013-304957","volume":"100","author":"A Dispenzieri","year":"2014","unstructured":"Dispenzieri A, Gertz MA, Kumar SK, Lacy MQ, Kyle RA, Saenger AK, et al. High sensitivity cardiac troponin T in patients with immunoglobulin light chain amyloidosis. Heart. 2014;100:383\u20138.","journal-title":"Heart"},{"key":"43_CR25","first-page":"136","volume":"11","author":"G Qian","year":"2014","unstructured":"Qian G, Wu C, Zhang Y, Chen YD, Dong W, Ren YH. Prognostic value of high-sensitivity cardiac troponin T in patients with endomyocardial-biopsy proven cardiac amyloidosis. J Geriatr Cardiol. 2014;11:136\u201340.","journal-title":"J Geriatr Cardiol"},{"key":"43_CR26","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.jacc.2013.03.055","volume":"62","author":"T Kubo","year":"2013","unstructured":"Kubo T, Kitaoka H, Yamanaka S, Hirota T, Baba Y, Hayashi K, et al. Significance of high-sensitivity cardiac troponin T in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2013;62:1252\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"43_CR27","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jjcc.2013.07.008","volume":"63","author":"Y Jenab","year":"2014","unstructured":"Jenab Y, Pourjafari M, Darabi F, Boroumand MA, Zoroufian A, Jalali A. Prevalence and determinants of elevated high-sensitivity cardiac troponin T in hypertrophic cardiomyopathy. J Cardiol. 2014;63:140\u20134.","journal-title":"J Cardiol"},{"key":"43_CR28","doi-asserted-by":"publisher","first-page":"85","DOI":"10.7326\/0003-4819-140-2-200401200-00008","volume":"140","author":"M Skinner","year":"2004","unstructured":"Skinner M, Sanchorawala V, Seldin DC, Dember LM, Falk RH, Berk JL, et al. High-dose melphalan and autologous stem cell transplantation in patietns with AL amyloidosis: an 8-year study. Ann Intern Med. 2004;140:85\u201393.","journal-title":"Ann Intern Med"},{"key":"43_CR29","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.jacc.2013.03.065","volume":"62","author":"S Takashio","year":"2013","unstructured":"Takashio S, Yamamuro M, Izumiya Y, Sugiyama S, Kojima S, Yamamoto E, et al. Coronary microvascular dysfunction and diastolic load correlate with cardiac troponin T release measured by a highly sensitive assay in patients with nonischemic heart failure. J Am Coll Cardiol. 2013;62:632\u201340.","journal-title":"J Am Coll Cardiol"},{"key":"43_CR30","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1093\/ejechocard\/jen017","volume":"9","author":"SS Abdelmoneim","year":"2008","unstructured":"Abdelmoneim SS, Bernier M, Bellavia D, Syed IS, Mankad SV, Chandrasekaran K, et al. Myocardial contrast echocardiography in biopsy-proven primary cardiac amyloidosis. Eur J Echocardiogr. 2008;9:338\u201341.","journal-title":"Eur J Echocardiogr"},{"key":"43_CR31","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1136\/hrt.2004.054015","volume":"92","author":"PM Elliott","year":"2006","unstructured":"Elliott PM, Kindler H, Shah JS, Sachdev B, Rimoldi OE, Thaman R, et al. Coronary microvascular dysfunction in male patients with Anderson-Fabry disease and the effect of treatment with alpha galactosidase A. Heart. 2006;92:357\u201360.","journal-title":"Heart"},{"key":"43_CR32","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1016\/j.amjcard.2011.01.029","volume":"107","author":"SA Timmer","year":"2011","unstructured":"Timmer SA, Germans T, Gotte MJ, Russel IK, Lubberink M, Ten Berg JM, et al. Relation of coronary microvascular dysfunction in hypertrophic cardiomyopathy to contractile dysfunction independent from myocardial injury. Am J Cardiol. 2011;107:1522\u20138.","journal-title":"Am J Cardiol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12872-015-0043-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-015-0043-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-015-0043-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-015-0043-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T07:43:46Z","timestamp":1551167026000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-015-0043-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,16]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["43"],"URL":"https:\/\/doi.org\/10.1186\/s12872-015-0043-z","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,16]]},"assertion":[{"value":"17 October 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"53"}}